Loading…
Sagimet Biosciences Inc. is projected to rise to $8.01 by 2027, a +11% move from its current price of $7.22. SGMT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.93 | $7.22 | $7.53 | +0.04% |
| May 30 | $6.81 | $7.23 | $7.66 | +0.08% |
| May 31 | $6.73 | $7.23 | $7.77 | +0.12% |
| Jun 1 | $6.65 | $7.23 | $7.86 | +0.17% |
| Jun 2 | $6.59 | $7.23 | $7.94 | +0.21% |
| Jun 3 | $6.54 | $7.24 | $8.01 | +0.25% |
| Jun 4 | $6.49 | $7.24 | $8.08 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.49 | $7.24 | $8.08 | +0.29% |
| Week 2 | $6.22 | $7.26 | $8.48 | +0.58% |
| Week 3 | $6.02 | $7.28 | $8.81 | +0.87% |
| Week 4 | $5.86 | $7.30 | $9.10 | +1.16% |
| Week 5 | $5.73 | $7.33 | $9.37 | +1.46% |
| Week 6 | $5.61 | $7.35 | $9.62 | +1.75% |
| Week 7 | $5.51 | $7.37 | $9.86 | +2.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sagimet Biosciences Inc., SGMT, is a clinical-stage biopharmaceutical company that develops novel therapeutics called fatty acid synthase (FASN) inhibitors for metabolic and fibrotic diseases in the United States. The lead drug candidate is Denifanstat, an oral, once-daily selective FASN inhibitor for metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer.
Sagimet also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019.
Sagimet was incorporated in 2006 and is headquartered in San Mateo, California.
Sagimet Biosciences Inc. (SGMT) is currently priced at $7.09 per share and has a market capitalization of $437.82M. It ranks 3139 by market cap.
The forecast table shows a path for the price from 2026 through 2050, with 2026 min $4.55, avg $7.09, max $9.49 and 2026 sentiment NEUTRAL. The 2030 avg is $11.23 with a min of $7.40 and a max of $18.45, and a 2030 sentiment BULLISH. The long-range outlook extends to 2040 with avg $27.11 and max $54.74, and to 2050 with avg $41.48 and max $94.35, with bullish sentiment across 2030–2050.
A major floor 39.2% below — a decisive break under it would weaken the trend.
The nearest floor, 18.8% below — buyers have tended to step in here.
The nearest ceiling, 21.2% above — a clean break opens room to run.
A major ceiling 40.8% above — clearing it would confirm fresh momentum.
Key SGMT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SGMT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.04 | Buy | $7.10 | Buy |
| MA 10 | $7.02 | Buy | $7.12 | Buy |
| MA 20 | $7.46 | Sell | $7.11 | Buy |
| MA 50 | $6.34 | Buy | $6.68 | Buy |
| MA 100 | $6.03 | Buy | $6.43 | Buy |
| MA 200 | $6.63 | Buy | $6.33 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.28 | Neutral |
| Stoch RSI (14) | 64.60 | Neutral |
| CCI (20) | -35.56 | Neutral |
| Williams %R (14) | -41.88 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -6.36 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 58.12 | Neutral |
| TRIX (15) | 0.54 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 53.34 | Neutral |
| Momentum (10) | -0.43 | Sell |
| Aroon Osc (25) | 8.00 | Buy |
| Hull MA (9) | 7.23 | Sell |
| ADX (14) | 13.81 | Neutral |
| ATR (14) | 0.25 | Info |
30-day technical picture: sentiment is NEUTRAL with RSI(14) at 50. The 50-day simple moving average is $6.26 and the 200-day simple moving average is $6.64. Support sits at $5.42 and resistance at $8.75. The 30-day trading range spans from $5.30 to $9.48.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.55 | $7.22 | $9.66 | 0% | Neutral | |
| $6.03 | $8.01 | $11.44 | +11% | Neutral | |
| $5.62 | $7.80 | $11.71 | +8% | Neutral | |
| $6.00 | $8.65 | $13.50 | +20% | Neutral | |
| $7.59 | $11.30 | $18.25 | +57% | Bullish | |
| $8.66 | $13.30 | $22.10 | +84% | Bullish | |
| $9.28 | $14.69 | $25.05 | +104% | Bullish | |
| $9.49 | $15.44 | $26.94 | +114% | Bullish | |
| $9.57 | $16.01 | $28.51 | +122% | Bullish | |
| $9.23 | $15.84 | $28.78 | +119% | Bullish | |
| $14.27 | $27.67 | $54.50 | +283% | Bullish | |
| $19.25 | $42.77 | $94.57 | +492% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.55 | $7.22 | $8.50 | +0.00% |
| June 2026 | $6.15 | $7.30 | $8.94 | +1.14% |
| July 2026 | $6.23 | $7.50 | $9.37 | +2.67% |
| August 2026 | $6.00 | $7.29 | $9.25 | -2.74% |
| September 2026 | $5.90 | $7.23 | $9.29 | -0.84% |
| October 2026 | $6.13 | $7.58 | $9.85 | +4.84% |
| November 2026 | $6.14 | $7.63 | $10.01 | +0.70% |
| December 2026 | $5.83 | $7.30 | $9.66 | -4.35% |
Click any year to see its month-by-month SGMT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sagimet Biosciences Inc.'s 2026 outlook centres on $7.22, within a $4.55 to $9.66 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SGMT could reach as high as $11.44, with a base case around $8.01 and support toward $6.03 — roughly +11% from $7.22. A consolidation phase looks the most probable path here.
Expect SGMT to range from $5.62 to $11.71 through 2028. The $7.80 average target implies a +8% move from current prices. That is -3% versus the projected 2027 average. Price action looks broadly range-bound.
The SGMT price prediction for 2029 points to an average of $8.65 (low $6.00, high $13.50) — a potential gain of +20% on today's $7.22. A consolidation phase looks the most probable path here.
In 2030, SGMT is projected to trade between $7.59 and $18.25, averaging $11.30 — a potential gain of +57% from today's $7.22. That is up +31% on the projected 2029 average. Momentum favours further upside here.
Sagimet Biosciences Inc.'s 2031 outlook centres on $13.30, within a $8.66 to $22.10 range. That is up +18% on the projected 2030 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SGMT could reach as high as $25.05, with a base case around $14.69 and support toward $9.28 — roughly +104% from $7.22. Momentum favours further upside here.
Expect SGMT to range from $9.49 to $26.94 through 2033. The $15.44 average target implies a +114% move from current prices. That is up +5% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SGMT price prediction for 2034 points to an average of $16.01 (low $9.57, high $28.51) — a potential gain of +122% on today's $7.22. Momentum favours further upside here.
In 2035, SGMT is projected to trade between $9.23 and $28.78, averaging $15.84 — a potential gain of +119% from today's $7.22. That is -1% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Sagimet Biosciences Inc.'s 2040 outlook centres on $27.67, within a $14.27 to $54.50 range. That is up +75% on the projected 2035 average. That marks a +283% change versus current levels. Momentum favours further upside here.
By 2050, SGMT could reach as high as $94.57, with a base case around $42.77 and support toward $19.25 — roughly +492% from $7.22. Buyers look set to stay in control over this stretch.
Investing $1,000 in SGMT today (≈ 138.504155 SGMT) could be worth
$5,923.73
+$4,923.73 (+492%) by 2050 · US Dollar
Based on the average projected SGMT price of $42.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SGMTwould be worth at today's price.
$1,000 invested in SGMT on May 27, 2025 (≈ 297.619057 SGMT) would be worth
$2,148.81
+$1,148.81 (+114.9%) today · 2.15× · US Dollar
Based on a SGMT entry price of $3.36 vs. today's $7.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.65 | $1,085.71 | +8.6% |
| 1 month ago | $8.12 | $889.16 | -11.1% |
| 3 months ago | $5.87 | $1,229.98 | +23.0% |
| 6 months ago | $7.22 | $1,000 | +0.0% |
| 1 year ago | $3.36 | $2,148.81 | +114.9% |
| All time (2.9y) ago | $15.95 | $452.66 | -54.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SGMT forecast.
Our base-case forecast reaches $14.00 around 2032.
Implied market cap at $14.00: $856.58M
Multi-year forecasts show a clear path to higher levels after 2029. The 2030 forecast has an average price of $11.23 with a max of $18.45 and a min of $7.40, accompanied by a 58.4 ROI and a BULLISH sentiment. The 2040 forecast projects an average of $27.11 with a max of $54.74 and a 282.4 ROI, remaining BULLISH.
By 2050 the average is $41.48 with a max of $94.35 and a 485 ROI, still BULLISH.
Overall, the longer-term outlook shows substantial upside potential from 2030 onward, but near-term moves are more uncertain with neutral momentum through 2029 and bullish momentum starting in 2030.
Tap a question to reveal the answer.
2030 average price is $11.23, with a min of $7.40 and a max of $18.45; ROI 58.4; sentiment BULLISH.
Forecasts show neutral sentiment in 2026–2029 and bullish sentiment from 2030–2050. The 2030 average is $11.23 and the 2050 average is $41.48, with a 2030 ROI of 58.4 and a 2050 ROI of 485.
The maximum forecast across 2026–2050 is $94.35 in 2050, so $100 is not supported by the provided forecast.
Current price is $7.09 and market cap is $437.82M. The rank is 3139.
The 30-day range is $5.30 to $9.48.
Sagimet Biosciences Inc. Community Discussion
0Share your Sagimet Biosciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.